MAPT and Alzheimer disease: Interestingly, antibodies raised in response to another trans-proline configuration, at P270 of the Tau molecule, can detect this isoform at more than 1000-fold higher levels in AD vs. non-AD brain samples, suggesting that local folding patterns are significantly disturbed in AD.